AmeriPharma’s premier pharmacy services are available in multiple states throughout the US.
Mon - Fri: 9:00AM - 10:00PM Sat - Sun: Closed

Related Posts

Welcome to Infusion Center

Get Financial Relief Now

Apply for Tafinlar Copay Assistance

Free service matches you with top copay assistance programs

Specialists assist you throughout the application process

Get automated updates on your funding status

Over $55 million secured for our patients to date

How Much Can You Save?

Speak With a Copay Assistance Specialist

We accept Medicare, multi-state Medicaid, Medi-Cal, Blue Shield, and most private insurances.

Medi-Cal logo
LegitScript approved

Get Started in Minutes

How Tafinlar Copay Assistance Works

plus icon with transparent background

1 – Check Your Coverage/Benefits Verification

Our team of expert billers finds the best avenues of coverage that minimize out-of-pocket costs.

Rx icon

2 – Transfer Prescription to AmeriPharma

We process your prescription by working with your previous pharmacy or prescriber, making the transition quick and easy.

document icon with transparent background

3 – Prior Authorization

Our team of specialists obtains approval from your insurance companies within 24 to 72 hours.

document and personnel icon with transparent background

4 – Copay Assistance & Financial Aid

We secure financial aid and decrease copays, out-of-pocket expenses, and high deductibles. To date, AmeriPharma Specialty Care has secured $55 million in financial assistance for our patients.

3 hands and plus icon with transparent background

5 – Nursing Care Coordination

AmeriPharma puts your schedule and home environment first when scheduling and coordinating one of our specialized nurses for your in-home infusions.

box icon with transparent background

6 – Delivery Coordination

Medications are always delivered in strict compliance with the specific requirements for immune globulin shipping. Next-day and overnight cold-chain deliveries are coordinated around your schedule.

Speak With a Specialist

We accept Medicare, multi-state Medicaid, Medi-Cal, Blue Shield, and most private insurances. Call us to find out more about your coverage.

What Is Tafinlar?

Tafinlar is the brand name for dabrafenib, an antineoplastic agent that belongs to a group called BRAF kinase inhibitors. BRAF stands for kinase B-raf, a protein in a cascade of signaling pathways that ultimately promotes cell proliferation and mobility. 

The most frequent mutation in BRAF occurs in the catalytic domain resulting in a single amino acid change, V600. This mutation results in an aberrant activation of cell growth, which promotes tumor cell survival and enhances mobility. 

Mutations in BRAF are seen in a number of cancers, mainly melanoma (40-60%), metastatic colorectal cancer (10-15%), non-small cell lung cancer (3%), breast cancer (3%), ovarian cancer (4%), glioma (11%) and papillary thyroid cancers (30-39%).

Schedule a Consultation

We accept Medicare, multi-state Medicaid, Medi-Cal, Blue Shield, and most private insurances. Call us to find out more about your coverage.

What Is Tafinlar Used To Treat?

Tafinlar is used to treat BRAF V600E and V600K-specific mutations seen in melanoma, as well as non-small cell lung cancer, solid tumors, and thyroid cancer. 

Your doctor will confirm BRAF V600 mutation status (in tumor specimens) prior to initiating Tafinlar. It is used either as a monotherapy, or in combination with Mekinist (trametinib), another antineoplastic agent that works by inhibiting another enzyme in the BRAF signaling pathway, called MEK protein. 

Tafinlar is taken orally and it comes in a capsule form of 50 mg and 75 mg, while Mekinist comes in a tablet form.

Copay and Financial Assistance

AmeriPharma Specialty Care alleviates financial burdens for patients and their families

Advanced software icon
Advanced software locates funding sources to match you with top-dollar foundation programs
Copay assistance icon
One of our copay assistance specialists will assist with the application process
Funding status icon
Automatic updates will be sent to you and your physician on the status of the funding

Speak With a Specialist

We accept Medicare, multi-state Medicaid, Medi-Cal, Blue Shield, and most private insurances. Call us to find out more about your coverage.

Tafinlar Side Effects

All drugs including Tafinlar have the potential to cause side effects. However, many people have no side effects or only minor side effects such as:

  • Hair loss
  • Hard or thick skin
  • Dry skin
  • Headaches
  • Joint pain
  • Muscle pain
  • Back pain
  • Constipation
  • Cough
  • Nose irritation
  • Throat irritation 

More serious side effects may occur, such as:

  • Bleeding
  • High blood sugar-like symptoms (confusion, fatigue, increased thirst, increased hunger, passing a lot of urine, flushing, fast breathing, or breath that smells like fruit)
  • Fluid and electrolytes imbalance 
  • Kidney problems
  • Stevens-Johnson syndrome/toxic epidermal necrolysis
  • Change in strength in one side of the body 
  • Heart problems
  • Mole changes
  • Eye/vision problems

Schedule a Consultation

We accept Medicare, multi-state Medicaid, Medi-Cal, Blue Shield, and most private insurances. Call us to find out more about your coverage.

Dosing Information

Melanoma, adjuvant treatment: 150 mg twice daily (in combination with trametinib); continue for up to 1 year in the absence of disease recurrence or unacceptable toxicity.

Melanoma, metastatic or unresectable: 150 mg twice daily (as a single-agent therapy or in combination with trametinib).

Non-small cell lung cancer, metastatic: 150 mg twice daily (in combination with trametinib).

Solid tumors, unresectable or metastatic: 150 mg twice daily (in combination with trametinib).

Thyroid cancer, anaplastic, locally advanced or metastatic: 150 mg twice daily (in combination with trametinib).

How Much Can You Save?

Speak With a Copay Assistance Specialist

© 2023 AmeriPharma Specialty Care. All Rights Reserved.  132 S. Anita Dr. Suite 310, Orange, CA 92868. Privacy Policy | Terms of use
Schedule a Consultation